673 related articles for article (PubMed ID: 27068454)
21. Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use.
Hoffman SL; Doolan DL; Sedegah M; Aguiar JC; Wang R; Malik A; Gramzinski RA; Weiss WR; Hobart P; Norman JA; Margalith M; Hedstrom RC
Vaccine; 1997 Jun; 15(8):842-5. PubMed ID: 9234529
[TBL] [Abstract][Full Text] [Related]
22. Isolation and Characterization of Vaccine Candidate Genes Including
Kim SH; Bae YA; Seoh JY; Yang HJ
Korean J Parasitol; 2017 Jun; 55(3):255-265. PubMed ID: 28719950
[TBL] [Abstract][Full Text] [Related]
23. Towards the design of heterovalent anti-malaria vaccines: a hybrid immunogen capable of eliciting immune responses to epitopes of circumsporozoite antigens from two different species of the malaria parasite, Plasmodium.
Kironde FA; Rao KV; Shah S; Kumar A; Sahoo N
Immunology; 1991 Oct; 74(2):323-8. PubMed ID: 1721043
[TBL] [Abstract][Full Text] [Related]
24. Minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites.
Mauduit M; Tewari R; Depinay N; Kayibanda M; Lallemand E; Chavatte JM; Snounou G; Rénia L; Grüner AC
Infect Immun; 2010 May; 78(5):2182-8. PubMed ID: 20194600
[TBL] [Abstract][Full Text] [Related]
25. Mice immunised with synthetic peptide from N-terminal conserved region of merozoite surface antigen-2 of human malaria parasite Plasmodium falciparum can control infection induced by Plasmodium yoelii yoelii 265BY strain.
Lougovskoi AA; Okoyeh NJ; Chauhan VS
Vaccine; 1999 Dec; 18(9-10):920-30. PubMed ID: 10580206
[TBL] [Abstract][Full Text] [Related]
26. Immunization of mice with Plasmodium TCTP delays establishment of Plasmodium infection.
Taylor KJ; Van TT; MacDonald SM; Meshnick SR; Fernley RT; Macreadie IG; Smooker PM
Parasite Immunol; 2015 Jan; 37(1):23-31. PubMed ID: 25376500
[TBL] [Abstract][Full Text] [Related]
27. Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection.
Labaied M; Harupa A; Dumpit RF; Coppens I; Mikolajczak SA; Kappe SH
Infect Immun; 2007 Aug; 75(8):3758-68. PubMed ID: 17517871
[TBL] [Abstract][Full Text] [Related]
28. Cellular immune response to DNA and vaccinia prime-boost immunization kills Plasmodium yoelii-infected hepatocytes in vitro.
Sacci JB; Hollingdale MR; Sedegah M
Pathog Dis; 2017 Jun; 75(4):. PubMed ID: 28475711
[TBL] [Abstract][Full Text] [Related]
29. A chemiluminescent-western blot assay for quantitative detection of Plasmodium falciparum circumsporozoite protein.
Kumar S; Zheng H; Sangweme DT; Mahajan B; Kozakai Y; Pham PT; Morin MJ; Locke E; Kumar N
J Immunol Methods; 2013 Apr; 390(1-2):99-105. PubMed ID: 23399449
[TBL] [Abstract][Full Text] [Related]
30. Immunization with the MAEBL M2 Domain Protects against Lethal Plasmodium yoelii Infection.
Leite JA; Bargieri DY; Carvalho BO; Albrecht L; Lopes SC; Kayano AC; Farias AS; Chia WN; Claser C; Malleret B; Russell B; Castiñeiras C; Santos LM; Brocchi M; Wunderlich G; Soares IS; Rodrigues MM; Rénia L; Costa FT
Infect Immun; 2015 Oct; 83(10):3781-92. PubMed ID: 26169268
[TBL] [Abstract][Full Text] [Related]
31. Cutting edge: a new tool to evaluate human pre-erythrocytic malaria vaccines: rodent parasites bearing a hybrid Plasmodium falciparum circumsporozoite protein.
Persson C; Oliveira GA; Sultan AA; Bhanot P; Nussenzweig V; Nardin E
J Immunol; 2002 Dec; 169(12):6681-5. PubMed ID: 12471098
[TBL] [Abstract][Full Text] [Related]
32. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
[TBL] [Abstract][Full Text] [Related]
33. Reduction of malaria transmission by transgenic mosquitoes expressing an antisporozoite antibody in their salivary glands.
Sumitani M; Kasashima K; Yamamoto DS; Yagi K; Yuda M; Matsuoka H; Yoshida S
Insect Mol Biol; 2013 Feb; 22(1):41-51. PubMed ID: 23176559
[TBL] [Abstract][Full Text] [Related]
34. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
[TBL] [Abstract][Full Text] [Related]
35. Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.
Powell TJ; Tang J; Derome ME; Mitchell RA; Jacobs A; Deng Y; Palath N; Cardenas E; Boyd JG; Nardin E
Vaccine; 2013 Apr; 31(15):1898-904. PubMed ID: 23481177
[TBL] [Abstract][Full Text] [Related]
36. From human antibody structure and function towards the design of a novel Plasmodium falciparum circumsporozoite protein malaria vaccine.
Wardemann H; Murugan R
Curr Opin Immunol; 2018 Aug; 53():119-123. PubMed ID: 29751213
[TBL] [Abstract][Full Text] [Related]
37. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.
Sauzet JP; Perlaza BL; Brahimi K; Daubersies P; Druilhe P
Infect Immun; 2001 Feb; 69(2):1202-6. PubMed ID: 11160023
[TBL] [Abstract][Full Text] [Related]
38. [Production and molecular characterization of Plasmodium falciparum recombinant circumsporozoite protein with 37 NANP and 4 NVDP epitopes].
Uyar Y; Akşit A; Karaca S; Ceylan ŞS; Yürük M
Mikrobiyol Bul; 2017 Jan; 51(1):41-51. PubMed ID: 28283009
[TBL] [Abstract][Full Text] [Related]
39. Editorial: The First Monoclonal Antibody Vaccine to Prevent Malaria Heralds a New Era of Malaria Vaccines to the Plasmodium falciparum Circumsporozoite Protein (PfCSP).
Parums DV
Med Sci Monit; 2021 Sep; 27():e934676. PubMed ID: 34511592
[TBL] [Abstract][Full Text] [Related]
40. Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain.
Goschnick MW; Black CG; Kedzierski L; Holder AA; Coppel RL
Infect Immun; 2004 Oct; 72(10):5840-9. PubMed ID: 15385485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
